SciSight Ecosystem
WoS SCIE Q3Scopus Q3SCImago #11,695CAS 4区Diamond OAHybrid

Turkish Journal of Hematology

Abbreviation (ISO):TURK J HEMATOL
Country: Turkey•WoS SCIE Quartile: Q3•Scopus SJR: 0.509•SCImago Rank: #11,695•Identifier (ISSN):1300-7777(Print)/1308-5263(Online)•Articles / Year: 31•Estimated Publication Fee (APC): Free (Diamond OA)
Clarivate IF (2026)Q3
1.6
↑ +0.3

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
14

14 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
31articles/year
98.84% Gold OA•97.14% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.50pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q3(IF: 1.6)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.50đ
WoS Q3(IF: 1.6)
🔵 Computed
20251.50đ
WoS Q3(IF: 1.3)
🔵 Computed
20241.50đ
WoS Q3(IF: 1.5)
🔵 Computed
20231.50đ
WoS Q3(IF: 2.6)
🔵 Computed
20221.50đ
WoS Q3(IF: 2.029)
🔵 Computed
20211.50đ
WoS Q3(IF: 1.831)
🔵 Computed
20201.50đ
WoS Q3(IF: 1.685)
🔵 Computed
20191.50đ
WoS Q3(IF: 0.779)
🔵 Computed
20181.50đ
WoS Q3(IF: 0.65)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

The Turkish Journal of Hematology is published quarterly (March, June, September, and December) by the Turkish Society of Hematology. It is an independent, non-profit peer-reviewed international English-language periodical encompassing subjects relevant to hematology. The Editorial Board of The Turkish Journal of Hematology adheres to the principles of the World Association of Medical Editors (WAME), International Council of Medical Journal Editors (ICMJE), Committee on Publication Ethics (COPE), Consolidated Standards of Reporting Trials (CONSORT) and Strengthening the Reporting of Observational Studies in Epidemiology (STROBE). The aim of The Turkish Journal of Hematology is to publish original hematological research of the highest scientific quality and clinical relevance. Additionally, educational material, reviews on basic developments, editorial short notes, images in hematology, and letters from hematology specialists and clinicians covering their experience and comments on hematology and related medical fields as well as social subjects are published. As of December 2015, The Turkish Journal of Hematology does not accept case reports. Important new findings or data about interesting hematological cases may be submitted as a brief report.

Topics Covered (Recognized by AI)
Medicine99.6%Biology93.5%Internal medicine90.1%Immunology71.2%Genetics69.9%Pathology55.6%Chemistry47.8%Surgery45.6%Biochemistry43.3%Psychology27%Gastroenterology24.6%Psychiatry24.2%Gene21.2%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #11,695Scopus Q3Diamond OASCImago Profile
Scopus Coverage:2000-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q3
0.509

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q3
Scopus H-Index (2025)
26

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
0.70

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
100% Free

Diamond Open Access: Authors publish completely free of charge with zero author-facing fees.

Diamond Open Access

Scopus 3-Year Publication & Citation Window

3-Year Citations149
3-Year Documents178
Citable Documents76

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate47.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HematologyQ3

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区HEMATOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Aves
Publication Language
English, Turkish
Frequency
Quarterly
Founding Year
1995
Editorial Address
AVES YAYINCILIK, IBRAHIM KARA, KIZILELMA CAD 5-3, FINDIKZADE, TURKEY, ISTANBUL, 34096
Indexing & Databases
SCIEScopusDOAJPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
HEMATOLOGY
JCRSCIE
74/103Q3
HEMATOLOGY
JCISCIE
74/103Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—5443
20251.39729
20241.56298
20232.677134
20222.02951142
20211.83176306
20201.68581390
20190.779125776
20180.6578303
2017—84631
2016—1531,114
2015—83543
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Turkish Journal of Hematology

WoS Q3
0123201820192020202120222023202420251.30
Annual Impact Factor Metric
2025:1.3

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 7f5748fc-1f72-4021-96f9-adf08daf3a95
Database Updated: 2026-10-01